New genomic analyses reveal a link between ancestry and head and neck cancer biology, with direct implications for risk stratification and targeted therapy. The study, led by researchers at the University of Maryland School of Medicine (UMSOM), underscores that genetic ancestry is a key determinant of tumor biology in head and neck squamous cell carcinoma (HNSCC), a factor that may help explain stark survival disparities and inform future precision medicine strategies. Further, the data spotlight ancestry-specific biomarkers and vulnerabilities, including upregulated genes such as POLB, that could reshape diagnostic and prognostic approaches.
The study, published in Cancer and Metastasis Reviews, analyzes data from 523 patients in The Cancer Genome Atlas determined that genetic ancestry, rather than self-identified…